Early vein isolation for atrial fibrillation in older adults
Part of Heart & circulation clinical trials.
This study compares doing vein isolation soon after diagnosis versus usual care in people 75+ with new or early atrial fibrillation. The goal is to see if early treatment prevents the condition from getting worse and improves quality of life.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 75 years of age or older.
- Your atrial fibrillation was first found less than 12 months ago and comes and goes (paroxysmal) or is early persistent.
- You have not had previous ablation (burning or freezing) for AF.
- You have not had valve replacement or heart-closure procedures.
- You do not have serious structural heart disease, recent stroke, or severe kidney failure.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new method called pulsed field ablation (PFA) to treat irregular heartbeats (atrial fibrillation) by isolating the veins that carry blood to your heart. It aims to see how well this procedure works and if it's safe for you.
This study tests a new way to find and treat the specific areas in the heart that cause atrial fibrillation to come back. It aims to improve the success of a repeat ablation procedure for people whose previous pulmonary vein isolation did not stop the irregular heartbeats.
This trial studies a modified ablation procedure that targets the superior vena cava in addition to the pulmonary veins to help stop episodes of paroxysmal (coming and going) atrial fibrillation. It may help people whose symptoms continue despite antiarrhythmic medicines.
This trial compares two ways to control atrial fibrillation (an irregular heartbeat) in older patients: destroying a small area of the heart's electrical pathway and implanting a pacemaker, versus a procedure to isolate the veins that trigger the irregular beats. The goal is to see which approach gives you better results and fits your preferences.
This study compares two different treatment strategies for atrial fibrillation (an irregular heartbeat) in people who also have heart failure. One strategy uses medications only, while the other includes a procedure to restore normal heart rhythm. The goal is to find the best way to improve symptoms and outcomes.
This study adds an extra step to the usual procedure for atrial flutter, where the doctor also isolates the pulmonary veins (the tubes bringing blood from the lungs) to lower the chance of future irregular heartbeats. It may help people with flutter who also have a higher stroke risk.
Hear when a new Atrial fibrillation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.